Episode Details

EP Edge Journal Watch Podcast — Issue 6 (January 2026)

Left Atrial Appendage Occlusion, AF Ablation Insights, Post-TAVR Conduction, ICU Anticoagulation & Translational EP Signals

EP Edge Journal Watch is your high-yield, evidence-driven electrophysiology podcast—designed for busy clinicians who want clinical relevance, mechanistic insight, and practice-changing nuance without wading through every paper.

In Issue 6 (January 2026), we anchor the episode around Left Atrial Appendage Occlusion (LAAO)—examining long-term randomized outcomes, implant mechanics that truly matter, and frontier strategies for the most complex patients—then expand into essential EP topics you’ll actually use on rounds.

What’s covered in this episode?

1.      LAAO vs Oral Anticoagulation — Long-Term Outcomes

We break down a contemporary randomized trial meta-analysis (including OPTION) examining:

• Stroke and systemic embolism
• Hemorrhagic vs non-procedural bleeding
• A provocative mortality signal favoring LAAO
   Practical implications for counseling ablation patients and high-bleeding-risk populations.

2.      WATCHMAN FLX Mechanics — Why Compression Matters

A deep dive into device sizing and compression:

• Over-compression thresholds
• Impact on peridevice leak (PDL)
• How this data should influence real-world implant decisions.

3.      Persistent LAA Thrombus — Is There a Salvage Path?

We discuss a multicenter experience using:

• Percutaneous aspiration thrombectomy
• Embolic protection strategies
• Same-session, no-touch LAA closure
   A feasibility signal—not for routine practice, but critical for expert centers facing clinical dead-ends.

OPTION Sub-Analysis — Does LAAO Worsen AF Recurrence?

Using the largest randomized dataset available:

• Concomitant vs staged LAAO with ablation
• AF recurrence, cardioversion, redo ablation
• Why “no AF recurrence” ≠ “no stroke risk”.

4.      Post-TAVR Conduction Disturbances

A physiology-forward look at:

• Intraprocedural vs delayed high-grade AV block
• HV interval and PR prolongation as rule-out tools
• Practical EP risk stratification after TAVR.

5.      Early Recurrence After Persistent AF Ablation

Insights from CAPLA challenge the traditional blanking period:

• Timing and burden of early recurrence
• Why late blanking-period events matter most
• How this should reshape post-ablation follow-up.

6.      Septic Shock + AF — ICU Anticoagulation Reality

A clinically uncomfortable but crucial topic:

• Therapeutic anticoagulation in septic shock
• Mortality vs bleeding tradeoffs
• Why EP input matters even in the ICU.

7.      Sex Hormones & Torsades de Pointes — A Translational EP Signal

A paradigm-shifting study linking:

• Hypogonadism, hyperestrogenism, and QT prolongation
• Cellular electrophysiology and real-world TdP severity
• A new biologic layer in arrhythmic risk.

Want more?

Subscribe to:

EP Edge Journal Watch (Weekly): https://lnkd.in/e-Wa4diC

A concise, high-yield weekly digest of the most important EP studies—curated, contextualized, and clinically translated so you don’t have to